Sort
15,273 grants matching “antimicrobial resistance”
Mechanism of Action
$517,287David R Andes · University Of Wisconsin-Madison · U19 · FY2016 · AI
Pattern Recognition Receptors and Autophagy in Mtb Control in AIDS
$516,688Vojo P Deretic · University Of New Mexico · R01 · FY2011 · AI
Inhibition of MEP pathway Isoprenoid Biosynthesis
$516,446Cynthia Schieck Dowd · George Washington University · R01 · FY2019 · AI
Acne and group A strep: an unknown burden
$516,355David J. Margolis · University Of Pennsylvania · R01 · FY2007 · AR
Radical SAM-dependent methylation in antibiotic resistance
$516,158Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2025 · AI
Interruption of Signaling-Mediated Bacterial Persistent Infections
$516,144Laurence G Rahme · Massachusetts General Hospital · R33 · FY2017 · AI
CAREER: Redefining 'antimicrobial' in the context of microbe-chemical interactions indoors
$516,000Erica M Hartmann · Northwestern University · · FY2021 · ENG
Relating impacts of antibiotics on the gut metabolome and microbiome to host physiology and weight
$515,919Peter Belenky · Brown University · R01 · FY2021 · DK
Genome Evolution During Bacterial Persistence in the Human Airways in COPD
$515,722Timothy F Murphy · State University Of New York At Buffalo · R01 · FY2022 · AI
NeoChip for specific and rapid identification of congenital CMV and neonatal HSV infections on minimal sample volume
$515,679Shelley M Lawrence · University Of Utah · R01 · FY2023 · HD
Interruption of Signaling-Mediated Bacterial Persistent Infections
$515,663Laurence G Rahme · Massachusetts General Hospital · R33 · FY2015 · AI
Perforin-2: The role of a novel antimicrobial protein in diabetic foot ulcers
$515,514Marjana Tomic-Canic · University Of Miami School Of Medicine · R01 · FY2018 · NR
Chicago Prevention and Intervention Epicenter II (CPIE-II)
$515,436Mary Katherine Hayden · Rush University Medical Center · U54 · FY2019 · CK
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
$515,415James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
Analysis of Metabolic Capabilities of Prokaryotic Cells
$515,407Jorge C Escalante · University Of Georgia · R35 · FY2019 · GM
Human macrophage variation & TB pathogenesis
$515,345Thomas R Hawn · University Of Washington · U19 · FY2024 · AI
Antimicrobial blue light inactivation of pathogenic microbes
$515,127Tianhong Dai · Massachusetts General Hospital · R01 · FY2019 · AI
Redefining the role of autophagy in bacterial disease
$515,124Ken Hashigiwa Cadwell · New York University School Of Medicine · R01 · FY2021 · AI
Adaptive alterations of lipids in mitis group streptococci
$515,054Kelli Lea Palmer · University Of Texas Dallas · R01 · FY2024 · AI
Adaptive alterations of lipids in mitis group streptococci
$515,054Kelli Lea Palmer · University Of Texas Dallas · R01 · FY2023 · AI
Genetic and Molecular Basis of Longevity
$515,016Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2015 · AG
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
$514,678Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Tim3 and Mycobacterium tuberculosis
$514,621Samuel M Behar · Brigham And Women'S Hospital · R01 · FY2012 · AI
Toward urinary catheterization with long-term resistance to bacterial colonization
$514,604Olga Zolotarskaya · Wynnvision, Llc · R44 · FY2023 · DK
Nitric Oxide and Severe Malaria
$514,245Duke University · R01 · FY2004 · AI